Lipobay: an effective lipid-lowering agent from Germany
Lipobay is one of the leading lipid-lowering drugs designed to reduce blood cholesterol levels. This drug, produced by the German company Bayer AG, belongs to the pharmacological group of HMG-CoA reductase inhibitors, which prevent the formation of cholesterol in the body.
The drug Lipobay contains the active substance cerivastatin sodium. It is available as film-coated tablets in various strengths including 0.1 mg, 0.2 mg, 0.3 mg and 0.4 mg. Cerivastatin sodium effectively reduces blood cholesterol levels and is widely used to treat primary hyperlipoproteinemia types IIA and IIB, as well as hypercholesterolemia, when diet therapy does not provide sufficient results.
However, before starting to take Lipobay, it is necessary to take into account contraindications. The drug is not recommended in case of hypersensitivity to its components, liver dysfunction, persistent increase in the activity of transaminases in the blood of unknown etiology, as well as during pregnancy, breastfeeding and childhood.
When using Lipobay, side effects may occur, such as flu-like syndrome, headache, rhinitis, sinusitis, cough, pain in the joints, back, abdomen, muscles and sleep disturbances.
It is important to note that Lipobay may interact with other drugs. For example, the absorption of Lipobay may be reduced when used simultaneously with cholestyramine and other ion exchange resins. It is also worth considering that derivatives of fibroic and nicotinic acids, as well as cyclosporine, increase the risk of developing myopathy when taken simultaneously with Lipobai.
In the event of an overdose of Lipobay, there is no information on specific manifestations and methods of treatment, so it is important to follow the recommended dosage and consult a doctor if necessary.
Before starting Lipobay therapy, it is necessary to conduct studies to exclude the secondary nature of hypercholesterolemia and check the functional state of the liver. During treatment, it is recommended to periodically monitor liver function indicators. In addition, with a history of liver disease, impaired renal function and other conditions predisposing to the development of renal failure, the drug should be used with caution. If blood cholesterol levels do not reach desired levels while using Lipobay, your doctor may consider combination treatment with other cholesterol-lowering medications.
It is important to remember that this information is current as of my last update in September 2021. You should always consult your doctor or pharmacist for the latest information about Lipobay or any other medicine.